BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation

By Iwamoto Takashi   Yamamoto Noriaki   Taguchi Tetsuya   Tamaki Yasuhiro   Noguchi Shinzaburo  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 69-77

Springer Publishing Company

Access to resources Recommend Favorite

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

By Hershman Dawn  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 529-537

Springer Publishing Company

Access to resources Recommend Favorite

Promoter methylation and the detection of breast cancer

By Brooks Jennifer  

Cancer Causes and Control, Vol. 20, Iss. 9, 2009-11 ,pp. : 1539-1550

Springer Publishing Company

Access to resources Recommend Favorite

p16 promoter hypermethylation is associated with increased breast cancer risk

By            

Molecular Medicine Reports, Vol. 6, Iss. 4, 2012-01 ,pp. : 904-908

Spandidos Publications

Access to resources Recommend Favorite

Prediagnostic plasma enterolactone levels and mortality among women with breast cancer

By Olsen Anja  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 883-889

Springer Publishing Company

Access to resources Recommend Favorite